gabexate has been researched along with Anterior Choroidal Artery Infarction in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomoto, Y | 1 |
| Hirose, Y | 1 |
| Tanaka, T | 1 |
| Kinoshita, H | 1 |
| Yamazaki, Y | 1 |
1 other study available for gabexate and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia, anomalous laboratory findings lead to the correct diagnosis.
Topics: Cerebral Infarction; Clinical Laboratory Techniques; Diagnosis, Differential; Follow-Up Studies; Gab | 2007 |